Timing and modalities of delivery according to treatment arm
| . | Nadroparin and medical surveillance . | Medical surveillance alone . | P . |
|---|---|---|---|
| Gestational week at delivery, mean (SD) | 38 (3.5) | 37 (4.6) | .69 |
| Delivery after 38th week, n (%) | 32 (52) | 41 (64) | .16 |
| Delivery at or before 38th week, n (%) | 30 (48) | 23 (36) | NA |
| Before 35th week, n (%) | 7 (11) | 10 (16) | .48 |
| Before 31st week, n (%) | 2 (3) | 3 (5) | 1.0 |
| Caesarean section, n (%) | 31 (50) | 24 (38) | .16 |
| . | Nadroparin and medical surveillance . | Medical surveillance alone . | P . |
|---|---|---|---|
| Gestational week at delivery, mean (SD) | 38 (3.5) | 37 (4.6) | .69 |
| Delivery after 38th week, n (%) | 32 (52) | 41 (64) | .16 |
| Delivery at or before 38th week, n (%) | 30 (48) | 23 (36) | NA |
| Before 35th week, n (%) | 7 (11) | 10 (16) | .48 |
| Before 31st week, n (%) | 2 (3) | 3 (5) | 1.0 |
| Caesarean section, n (%) | 31 (50) | 24 (38) | .16 |
Timing and modalities not available in 1 of the 63 treated and in 1 of the 65 nontreated women with data on pregnancy outcome.
NA indicates not applicable.